Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Foods ; 12(13)2023 Jun 30.
Article in English | MEDLINE | ID: mdl-37444313

ABSTRACT

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract. To explore the preventive effects of dietary foods on IBD, we evaluated the effects of the traditional Japanese fermented beverage "Amazake" on gut barrier function in this study. Black koji Amazake (BA) derived from Aspergillus luchuensis MEM-C strain and yellow koji Amazake (YA) derived from Aspergillus oryzae were made in this study, and their nutrients were analyzed. Mice with mild gut barrier dysfunction induced by Western diet were administered with 10% of each Amazake for two months. Mice gut microbiota were analyzed by 16S rRNA gene sequencing. BA contained a higher amount of isomaltooligosaccharides, citric acid, and ferulic acid than YA. The animal data revealed that BA significantly induced the expressions of antioxidant factors and enzymes such as NF-E2-related factor 2 (Nfr2), heme oxygenase 1 (HO1), and superoxide dismutase-2 (SOD-2). The gut barrier protein, occludin, and fecal immunoglobulin A (IgA) were also significantly enhanced by BA. Furthermore, the levels of serum endotoxin and hepatic monocyte chemotactic protein-1 (MCP-1) were decreased in both the BA and YA groups. In gut microbiota, Lachnospiraceae was increased by BA while Akkermansia muciniphilia was increased by YA. Black koji Amazake contained a higher amount of isomaltooligosaccharides, citric acid, and ferulic acid than yellow koji Amazake and contributed to protecting gut barrier function to reduce endotoxin intrusion and inflammation.

2.
Masui ; 57(6): 764-7, 2008 Jun.
Article in Japanese | MEDLINE | ID: mdl-18546912

ABSTRACT

BACKGROUND: In recent years, workload for a doctor has been increasing, because hospital managers are trying to improve the efficiency of management. As a result, many doctors are expected to work harder. We studied how anesthesiologists are stressed by their work, especially on working overnight, using the Profile of Mood States(POMS). METHODS: Thirty six anesthesiologists working in our hospital are studied. We asked them to answer POMS questionnaires three times at 8:00 before overnight work, 8:00 and 17:00 the following day. RESULTS: Mean working time for overnight job is 32 +/- 4.3 hours and mean sleeping time is 3.0 +/- 1.3 hours (mean +/- SD). The Profile of Mood States has six subscores (depression, fatigue, vigor, confusion, tension/anxiety, and anger). After working overnight, fatigue and confusion scores were significantly increased and vigor scores were significantly decreased, compared with the sores at 8.00 before overnight work. CONCLUSIONS: We studied anesthesiologist's stress of working overnight, using the Profile of Mood States. As a result, after overnight work, fatigue, confusion and vigor scores were significantly exacerbated. We speculate that the anesthesiologists are building up so much stress when they work overnight as on call.


Subject(s)
Anesthesiology , Stress, Psychological/diagnosis , Adult , Affect , Fatigue , Female , Humans , Male , Psychological Tests , Work Schedule Tolerance
3.
Clin Rheumatol ; 25(3): 415-8, 2006 May.
Article in English | MEDLINE | ID: mdl-16234995

ABSTRACT

We report a female patient with IgA nephropathy associated with undifferentiated spondyloarthropathy. The patient manifested proteinuria and microhematuria and was diagnosed as having IgA nephropathy based on the histopathologic findings of the renal biopsy. Two years later, the bone X-ray demonstrated syndesmophytes and multiple calcifications in the ligament and tendon insertions, suggestive of long-term enthesitis, but the patient had occasionally noticed mild lumbago up to the time she visited our hospital, with spontaneous pain in the bilateral shoulders and lower back. IgA nephropathy can be concomitant with a mild form of seronegative spondyloarthropathy in women. Possible association of this disorder should be carefully checked in patients with IgA nephropathy irrespective of clinical symptoms suggesting the arthropathy, particularly in women.


Subject(s)
Glomerulonephritis, IGA/complications , Proteinuria/etiology , Rheumatic Diseases/complications , Spondylarthropathies/complications , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Biopsy , Drug Therapy, Combination , Female , Glomerulonephritis, IGA/drug therapy , Glomerulonephritis, IGA/pathology , Hematuria/etiology , Humans , Injections, Intra-Articular , Kidney/pathology , Middle Aged , Prednisolone/therapeutic use , Proteinuria/drug therapy , Radiography , Rheumatic Diseases/drug therapy , Rheumatic Diseases/pathology , Spine/diagnostic imaging , Spine/pathology , Spondylarthropathies/drug therapy , Spondylarthropathies/pathology , Treatment Outcome , Triamcinolone Acetonide/administration & dosage , Triamcinolone Acetonide/therapeutic use
4.
Int J Mol Med ; 14(5): 813-8, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15492850

ABSTRACT

Molecular defects of TNFRSF1A was investigated in members of a family presenting with typical phenotypes of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) and in patients with the autoimmune disorders, systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Genomic DNA from the members of a family with typical TRAPS, as well as from 100 patients with SLE, 100 patients with RA and 100 healthy individuals, was studied for mutations in exons 2, 3 and 4 of the TNFRSF1A gene. All individuals were Japanese. Three novel missense mutations were identified in the TNFRSF1A. The C70G mutation was identified in family members with typical TRAPS, which was the second case in eastern Asian population. In addition, the T61I and R104Q mutations were each identified in 2 of the 100 SLE patients. The T61I mutation was identified in one of the 100 healthy individuals. No mutations were identified in the 100 RA patients. Functional analysis revealed that PMA-induced shedding of TNFRSF1A from PBMCs was impaired in a patient carrying T61I. A larger scale of study will clarify whether these two mutations, T61I and R104Q, are associated with chronic inflammatory disorders, such as SLE, or not.


Subject(s)
Lupus Erythematosus, Systemic/genetics , Mutation , Receptors, Tumor Necrosis Factor, Type I/genetics , Receptors, Tumor Necrosis Factor/genetics , Amino Acid Sequence , Amino Acid Substitution , Arthritis, Rheumatoid/genetics , Base Sequence , Female , Humans , Japan , Male , Pedigree , Periodicity , Polymerase Chain Reaction , Polymorphism, Single Nucleotide
SELECTION OF CITATIONS
SEARCH DETAIL
...